Skip to content
The Nexus
DossierENTITY

compassionate use

Coverage of compassionate use in the Nexus archive.

Earliest in view: Jun 23 · 14:22 UTCMost recent: Jun 25 · 18:58 UTC
Co-mentioned in this coverage
Eli Lillyorganization2Lizzy Lawrenceperson2retatrutidetopic1Food and Drug Administrationorganization1The Readout LOUDorganization1hair loss drugstopic1GLP-1topic1STATorganization1
Recent coverage
  • HEALTHJun 25 · 18:58 UTCSTAT NEWS
    The mysterious case of Eli Lilly’s obesity drug

    Eli Lilly's obesity drug retatrutide is being made available to one individual through the FDA's 'compassionate use' program. The article discusses this development alongside broader questions about drugmaker acquisitions and the investment potential of hair loss drugs, as covered in a podcast episode.

  • HEALTHJun 23 · 14:22 UTCSTAT NEWS
    STAT+: Exclusive: Mystery man gets experimental GLP-1

    A man was granted compassionate-use access to an experimental GLP-1 drug developed by Eli Lilly. The exclusive report details the sole individual given special access to the obesity treatment, as covered in STAT's health policy newsletter.

compassionate use · Dossier · The Nexus